Dysregulation of HSG triggers vascular proliferative disorders
Kuang-Hueih Chen1, Xiaomei Guo, Dalong Ma
1The Institute of Cardiovascular Science & The Institute of Molecular Medicine, Peking University, Beijing 100083, China.
Insights
A novel gene, hyperplasia suppressor gene (HSG), also known as rat mitofusin-2, was identified as a key regulator of vascular cell proliferation. Reduced HSG expression is linked to cardiovascular diseases like atherosclerosis and restenosis.
Area of Science:
- Molecular Biology
- Cardiovascular Research
- Genetics
Background:
- Vascular proliferative disorders, including atherosclerosis and restenosis, are leading causes of cardiovascular disease.
- A common underlying molecular mechanism for these conditions has not been fully elucidated.
Purpose of the Study:
- To identify and characterize a novel gene involved in suppressing vascular hyperplasia.
- To investigate the role of this gene in the pathogenesis of vascular proliferative disorders.
Main Methods:
- Identified and characterized a novel hyperplasia suppressor gene (HSG), later identified as rat mitofusin-2 (rHSG).
- Assessed HSG expression levels in vascular smooth muscle cells (VSMCs) from various disease models (spontaneously hypertensive rats, balloon-injured rats, ApoE-knockout mice).
- Evaluated the effect of HSG overexpression on VSMC proliferation in vitro and neointimal hyperplasia in vivo.
Main Results:
- HSG expression was significantly reduced in hyper-proliferative VSMCs from diseased arteries.
- Overexpression of HSG suppressed VSMC proliferation, inhibited ERK/MAPK signaling, and induced cell-cycle arrest.
- HSG effectively blocked balloon injury-induced neointimal VSMC proliferation and restenosis in rat carotid arteries.
- The anti-proliferative effect was independent of mitochondrial fusion, linked to the p21(ras) motif.
Conclusions:
- Rat mitofusin-2 (rHSG) functions as a crucial suppressor of vascular cell proliferation.
- Dysregulation or reduced expression of rHSG contributes to the development of vascular proliferative disorders such as atherosclerosis and restenosis.
- rHSG represents a potential therapeutic target for cardiovascular diseases.
Abstract:
Vascular proliferative disorders, such as atherosclerosis and restenosis, are the most common causes of severe cardiovascular diseases, but a common molecular mechanism remains elusive. Here, we identify and characterize a novel hyperplasia suppressor gene, named HSG (later re-named rat mitofusin-2). HSG expression was markedly reduced in hyper-proliferative vascular smooth muscle cells (VSMCs) from spontaneously hypertensive rat arteries, balloon-injured Wistar Kyoto rat arteries, or ApoE-knockout mouse atherosclerotic arteries. Overexpression of HSG overtly suppressed serum-evoked VSMC proliferation in culture, and blocked balloon injury induced neointimal VSMC proliferation and restenosis in rat carotid arteries. The HSG anti-proliferative effect was mediated by inhibition of ERK/MAPK signalling and subsequent cell-cycle arrest. Deletion of the p21(ras) signature motif, but not the mitochondrial targeting domain, abolished HSG-induced growth arrest, indicating that rHSG-induced anti-proliferation was independent of mitochondrial fusion. Thus, rHSG functions as a cell proliferation suppressor, whereas dysregulation of rHSG results in proliferative disorders.
More Related Videos
11:38Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay
Published on: September 14, 2021
05:30Trophoblast Cell Recovery from Angiogenesis-Tube Formation Assay for Differentiation Marker Expression Analysis
Published on: November 8, 2024
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Vascular Spasm
TGF - β Signaling Pathway
Regulation of Hematopoietic Stem Cells
Hyperosmolar Hyperglycemic State
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
